SCHEMBL28833452

SCHEMBL28833452

Nc1ncccc1-c1ncc2[nH]cnc2n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.50
KDM4E B2RXH2 1/20 0.42
CDK2 P24941 3/20 0.41
MKNK1 Q9BUB5 2/20 0.41
MKNK2 Q9HBH9 2/20 0.41
CDK1 P06493 2/20 0.41
RXFP1 Q9HBX9 1/20 0.41
NUDT1 P36639 1/20 0.38
MAP4K4 O95819 1/20 0.36
CCNT1 O60563 1/20 0.36
CCNB1 P14635 1/20 0.36
CDK7 P50613 1/20 0.36
CDK9 P50750 1/20 0.36
CCNH P51946 1/20 0.36
PIM1 P11309 1/20 0.34
TGFBR1 P36897 1/20 0.34
PAK1 Q13153 1/20 0.34
MTOR P42345 1/20 0.34
BRD4 O60885 1/20 0.33
ADORA2A P29274 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4875493 0.77 ALDH1A1 (0.53) ALDH1A1KDM4ECDK2CDK1RXFP1
SCHEMBL27695978 0.76 CDK2 (0.47) ALDH1A1KDM4ECDK2RXFP1PIM1
SCHEMBL29452971 0.75 ALDH1A1 (0.63) ALDH1A1KDM4ECDK2CDK1RXFP1
SCHEMBL4924100 0.74 KDM4E (0.48) ALDH1A1KDM4ECDK2
SCHEMBL503815 0.73 PARP1 (0.48) ALDH1A1KDM4ECDK2CDK1RXFP1
SCHEMBL6385068 0.73 QPCT (0.50) ALDH1A1KDM4ECDK2PIM1ADORA2A
SCHEMBL680856 0.71 CDK2 (0.55) ALDH1A1KDM4ECDK2RXFP1ADORA2A
SCHEMBL29906262 0.71 ALDH1A1 (0.54) ALDH1A1KDM4ECDK2RXFP1PAK1
Hydrochloric Acid SCHEMBL4456682 0.70 CDK2 (0.54) ALDH1A1KDM4ECDK2RXFP1ADORA2A
SCHEMBL1732673 0.69 MKNK1 (0.44) CDK2MKNK1MKNK2CDK1MAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3412670-B1 PYRIDINE DERIVATIVES INHIBITING RAF KINASE AND VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR, PHARMACEUTICAL COMPOSITION CONTAINING THEM AND USE THEREOF SAMJIN PHARM CO LTD (KR) 2022-03-09 EP disclosed
CN-106243047-B The double aryl ureas of quinokysalines with VEGFR-2 and B-raf double inhibition effect and its derivative, preparation method and applications 江苏神华药业有限公司 2019-07-23 CN disclosed
CN-106243047-A There are the double aryl ureas of quinokysalines and derivant, the preparation method and applications of VEGFR 2 and B raf double inhibition effect 江苏神华药业有限公司 2016-12-21 CN disclosed